WEDNESDAY, Nov. 6 (HealthDay News) -- A new clinical trial
appears to have dashed hopes that the most popular drug for
treating type 2 diabetes might also be able to reduce the risk of
heart attack and stroke in nondiabetics.
Previously, diabetes patients who took metformin, a safe and
effective blood sugar-lowering pill, experienced a 39 percent lower
risk of heart attack over 10 years in a landmark drug trial in the
Based on those findings, researchers with the University of
Glasgow, in Scotland, set out to see whether metformin would
provide similar cardiovascular benefits for people who don't have
The new results, published online Nov. 7 in
The Lancet Diabetes & Endocrinology, are disappointing,
the study authors said.
"We didn't find that any markers of heart risk really looked like they improved in any meaningful way," said study leader Dr. David Preiss, a clinical senior lecturer at the BHF Glasgow Cardiovascular Research Center and the University of Glasgow.
The drug did not have any effect on hardening of the arteries in
the neck (the "carotid" arteries), or on the amount of carotid
plaque in the blood vessels, the researchers reported. There also
were no significant changes in cholesterol or triglyceride (blood
fat) levels, or in blood pressure.
However, the drug did prompt weight loss among study
participants, opening the door for its potential use as a safe
weight-control medication. People taking the drug lost an average
of 7 pounds over the course of the 18-month study and had improved
blood sugar levels.
"Some people probably use it for that already," Preiss said of metformin's potential as a weight-loss medication. "If you look at the drugs that have been used for weight loss, without exception they've been disastrous and nearly all have been pulled from the market. This drug gave you the kind of weight loss you can get on those medications, and it reduces your risk of diabetes as well."
Metformin has been gaining a reputation as a potential miracle
drug. Other studies have shown that it may reduce risk of dementia
and cancer of the prostate and pancreas.
The new drug trial involved 173 people who were randomly
assigned to take either metformin or an inactive placebo for 18
months. Participants did not have diabetes but already had heart
disease and weight problems, and were taking statins to control
their cholesterol levels.
After 18 months, the researchers found no improvement in any of
their risk factors for heart attack.
"Right now, physicians would not treat patients who are like this with metformin, so this study supports the fact that metformin has no short-term benefit for people with heart disease," said Dr. Robert Eckel, a professor of medicine at the University of Colorado Anschutz Medical Campus. "There were some metabolic benefits, but this study in no way indicates the need to treat patients with heart disease with metformin."
Metformin apparently causes weight loss through appetite
suppression, but that weight loss cannot fully account for the
improvement in heart attack risk that people with type 2 diabetes
enjoy when they take the pill, said Eckel, a past president of the
American Heart Association.
"The metformin benefit is in part related to better diabetes control, in part related to weight control and in part due to factors that haven't been identified yet," he said.
The case isn't completely closed on metformin, however. A large
trial involving 12,000 patients currently is testing the drug's
ability to control blood sugar levels in nondiabetics, but
researchers also will look at the data to see if heart attack risk
"We have to be cautious because big trials have surprised us before and will surprise us again," said study author Preiss. "I wouldn't rule it out of having some benefit, but if something fails to improve cholesterol or blood pressure, I for one would be cautious about giving it a big sell-up."
For more about metformin, visit the
University of California, San Francisco.
EBSCO Information Services is fully accredited by URAC. URAC is an independent, nonprofit health care accrediting organization dedicated to promoting health care quality through accreditation, certification and commendation.
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.
Copyright © EBSCO Information Services. All rights reserved.